Cisatracurium Besylate
- Product NDC
- 71288-720
- Requested package NDC
- 71288-720-96
- 11-digit product format
- 712880720
- Labeler code
- 71288
- Product ID
- 71288-720_8b571399-d78e-4ff1-b1ec-20112b898aac
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cisatracurium Besylate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Meitheal Pharmaceuticals Inc.
- Application
- ANDA211668
- Marketing category
- ANDA
- Marketing start
- 2019-10-31
- Marketing end
- 0000-00-00
- Substance
- CISATRACURIUM BESYLATE
- Active strength
- 10 mg/5mL
- Pharmacologic classes
- Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 71288-720 | 71288-720-96 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 71288-720 | 71288-720-96 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 71288-720 | 71288-720-96 | D | Discontinued by firm | excluded / ndc_excluded.zip | f5e01cc5f278… | a2eaf40c39c3… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211668-001 | CISATRACURIUM BESYLATE | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 |
| A211668-002 | CISATRACURIUM BESYLATE | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A211668-001 | AP |
| A211668-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A211668-001 | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A211668-002 | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A211668-001 | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A211668-002 | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A211668-001 | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A211668-002 | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211668-001 | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211668-002 | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A211668-001 | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A211668-002 | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211668-001 | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211668-002 | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211668-001 | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211668-002 | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211668-001 | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211668-002 | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211668-001 | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211668-002 | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211668-001 | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211668-002 | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211668-001 | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211668-002 | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A211668-001 | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A211668-002 | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211668-001 | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211668-002 | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211668-001 | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211668-002 | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211668-001 | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211668-002 | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A211668-001 | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A211668-002 | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2019-04-25 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A211668-001 | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | 2019-04-25 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A211668-002 | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | 2019-04-25 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A211668-001 | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | 2019-04-25 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A211668-002 | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | 2019-04-25 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A211668-001 | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | 2019-04-25 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A211668-002 | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | 2019-04-25 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A211668-001 | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE / INJECTION | AP | 2019-04-25 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A211668-002 | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE / INJECTION | AP | 2019-04-25 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A211668-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A211668-002 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A211668-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A211668-002 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A211668-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A211668-002 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211668-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211668-002 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A211668-001 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A211668-002 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211668-001 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211668-002 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211668-001 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211668-002 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211668-001 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211668-002 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211668-001 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211668-002 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211668-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211668-002 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211668-001 | AP | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211668-002 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A211668-001 | AP | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A211668-002 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211668-001 | AP | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211668-002 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211668-001 | AP | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211668-002 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211668-001 | AP | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211668-002 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A211668-001 | AP | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A211668-002 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A211668-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A211668-002 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A211668-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A211668-002 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A211668-001 | AP | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A211668-002 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A211668-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A211668-002 | AP | 1 | 74a2ff9319b5… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71288-720-95 | ML - Milliliter | 71288-720 | 44704881-9fc4-4226-9db3-f6623b8660bd | 1 | 2021-10-08 |
| 71288-720-96 | ML - Milliliter | 71288-720 | 2c3798ce-aeca-47b7-9a76-639b70b37c7d | 1 | 2021-10-08 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cisatracurium Besylate | CISATRACURIUM BESYLATE | Meitheal Pharmaceuticals Inc. | 1be30efe-4beb-411a-bf82-6e4ea68fd262 | 2023-06-05 | Warnings, Adverse reactions | 211668 ANDA211668 |
| Cisatracurium Besylate | CISATRACURIUM BESYLATE | Meitheal Pharmaceuticals Inc. | 7c8c41b6-d07c-4740-84b7-603289104c59 | 2023-01-19 | Warnings, Adverse reactions | 211668 ANDA211668 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 71288-720-96 | 71288072096 | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-720-96) > 5 mL in 1 VIAL, SINGLE-DOSE (71288-720-95) | 2019-10-31 | 0000-00-00 | No | No | Current |